Novartis Institutes for BioMedical Research
Biochemist and molecular biologist (University of Strasbourg, France). Senior scientist with more than 20 years of experience within Novartis in three different units: DMPK (preclinical), Clinical Pharmacology (development) and lately ADME (discovery). Provides data and expert advice companywide in DMPK areas with focus on mitigation of issues related to metabolism and drug interactions. Author of 30+ peer reviewed papers with 1300+ citations.